Retrospektive Studie zu Patientinnen, Die pranatal, Perinatal Oder Postnatal Prophylaktisch Oder Therapeutisch Mit Fondaparinux Behandelt Wurden.

Trial Profile

Retrospektive Studie zu Patientinnen, Die pranatal, Perinatal Oder Postnatal Prophylaktisch Oder Therapeutisch Mit Fondaparinux Behandelt Wurden.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Thromboembolism
  • Focus Adverse reactions
  • Acronyms FondaPPP
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 Nov 2010 Actual end date (1 Jul 2010) added as reported by ClinicalTrials.gov record.
    • 05 Nov 2010 Actual initiation date changed from 1 Feb 2010 to 1 May 2010 as reported by ClinicalTrials.gov record.
    • 05 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top